Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1995-06-07
1997-10-14
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 19, 514363, 514364, 530330, 530331, 548139, 548144, C07K 508, C07K 506, A61K 3141
Patent
active
056772823
ABSTRACT:
Amino acid amides of 5-amino-1,3,4-thiadiazole-2-thione are disclosed. These compounds inhibit matrix metalloproteinase enzymes and cartilage degradation. Methods of treating diseases caused by over-activity of matrix metalloproteinases, such as osteoarthritis and rheumatoid arthritis, are also disclosed.
REFERENCES:
Cho, N. S. and Kim, G. N., "Synthesis of 5-Aroylamino-3H-1,3,4-Thiadiazole-2-Thiones and Their Tautomerism," J. Heterocyclic Chem., 30:397 (1993).
Suiko, M., et al., "Relationship Between the Structures and Cytotoxic Chem., 46(11):2691-2695 (1982).
Jacobson Alan R.
Oleksyszyn Jozef
Gerstl Robert
ProScript, Inc.
LandOfFree
Amino acid amides of 1,3,4-thiadiazoles as matrix metalloprotein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid amides of 1,3,4-thiadiazoles as matrix metalloprotein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid amides of 1,3,4-thiadiazoles as matrix metalloprotein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1555338